// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Parametric response map registered CT feature and small airway physiology analysis in asthma

Alexander Bell - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis

Paul Hughes - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Cystic Fibrosis

N/A

A pre-lung cancer clinic multidisciplinary team meeting (MDT) and selection of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) a first line investigation reduces time to diagnosis

Faheem Khan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Current practice: safety checklists for pleural procedures

Patrick Bradley - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of cryotherapy for obstructive endobronchial lesions: a review

Julia Beeson - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

BT10+ study design: 10 year follow-up of subjects receiving bronchial thermoplasty (BT) in 3 randomized controlled studies

Rekha Chaudhuri - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical and histological effects of Bronchial Thermoplasty in severe asthma

Richard Russell - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Endoscopic valve removal >180 days since implantation in patients with severe emphysema

Daniela Gompelmann - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pneumothorax

N/A

Targeted Lung Denervation improves COPD symptoms and health related quality of life at 6-months

Dirk-Jan Slebos - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) sampling for molecular testing in pulmonary adenocarcinoma

Neena Kalsi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The effect of 19G EBUS-TBNA biopsies on characterisation of malignant and benign disease

Rachel Jones - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pneumomediastinum following EBUS-TBNA in patients with Pulmonary Fibrosis

Louise Brockbank - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

N/A

Does rapid onsite cytology provided by a biomedical scientist (BMS) affect the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)? A repeat audit of the experience of a UK general hospital.>

Alexandra Ewence - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

N/A

EBUS-TBNA in isolated mediastinal/hilar lymphadenopathy: diagnostic performance in a high volume UK center

Sasiharan Sithamparanathan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of quitting smoking at the time of diagnosis of lung cancer on survival

Rachel Gemine - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Comparison of demographics in quitters compared to continued smokers in patients with lung cancer

Rachel Gemine - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Non Small Cell Lung Cancer and impact of comorbidities, symptoms, access and time spent in the Emergency Department and hospitalizations: a retrospective single center case note analysis

Carlo Barbetta - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Non Small Cell Lung cancer

N/A

Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status

Vytis Dudzevicius - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Use of a rapid access email referral system in lung cancer: Diagnosing Cancer Earlier?North Edinburgh Lung cancer service Western General Hospital

Karuna Sapru - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment

Nneka Nwosu - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Copyright © 2026. QuantiNova All rights reserved